Kenya Patient Summary FHIR Implementation Guide
0.1.0 - ci-build
Kenya Patient Summary FHIR Implementation Guide, published by Digital Health Agency of Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/Kenya-Patient-Summary-FHIR-IG/ and changes regularly. See the Directory of published versions
| Official URL: https://nshr-uat.sha.go.ke/fhir/ValueSet/kps-medication-vs | Version: 0.1.0 | |||
| Draft as of 2026-06-19 | Computable Name: KPSMedicationVS | |||
Copyright/Legal: Copyright © 2024+ Digital Health Agency of Kenya. This content is licensed under Creative Commons Zero v1.0 Universal (CC0 1.0). No rights reserved. |
||||
List of permitted medications in national formulary.
References
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs version 📦0.1.0
Expansion performed internally based on codesystem Medication ATC CodeSystem v0.1.0 (CodeSystem)
This value set contains 1,000 concepts
| System | Code | Display (en) | JSON | XML |
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A | ALIMENTARY TRACT AND METABOLISM | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01 | STOMATOLOGICAL PREPARATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01A | STOMATOLOGICAL PREPARATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA | Caries prophylactic agents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA01 | sodium fluoride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA02 | sodium monofluorophosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA03 | olaflur | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA04 | stannous fluoride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AA51 | sodium fluoride, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB | Antiinfectives and antiseptics for local oral treatment | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB02 | hydrogen peroxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB03 | chlorhexidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB04 | amphotericin B | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB05 | polynoxylin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB06 | domiphen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB07 | oxyquinoline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB08 | neomycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB09 | miconazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB10 | natamycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB11 | various | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB12 | hexetidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB13 | tetracycline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB14 | benzoxonium chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB15 | tibezonium iodide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB16 | mepartricin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB17 | metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB18 | clotrimazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB19 | sodium perborate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB21 | chlortetracycline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB22 | doxycycline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB23 | minocycline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB24 | octenidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB25 | oxytetracycline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AB53 | chlorhexidine and cetylpyridinium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AC | Corticosteroids for local oral treatment | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AC01 | triamcinolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AC02 | dexamethasone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AC03 | hydrocortisone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AC04 | prednisolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AC54 | prednisolone, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD | Other agents for local oral treatment | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD01 | epinephrine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD02 | benzydamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD05 | acetylsalicylic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD06 | adrenalone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD07 | amlexanox | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD08 | becaplermin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A01AD11 | various | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02 | DRUGS FOR ACID RELATED DISORDERS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02A | ANTACIDS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA | Magnesium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA01 | magnesium carbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA02 | magnesium oxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA03 | magnesium peroxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA04 | magnesium hydroxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA05 | magnesium silicate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AA10 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB | Aluminium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB01 | aluminium hydroxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB02 | algeldrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB03 | aluminium phosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB04 | dihydroxialumini sodium carbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB05 | aluminium acetoacetate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB06 | aloglutamol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB07 | aluminium glycinate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AB10 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AC | Calcium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AC01 | calcium carbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AC02 | calcium silicate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AC10 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AD | Combinations and complexes of aluminium, calcium and magnesium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AD01 | ordinary salt combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AD02 | magaldrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AD03 | almagate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AD04 | hydrotalcite | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AD05 | almasilate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AF | Antacids with antiflatulents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AF01 | magaldrate and antiflatulents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AF02 | ordinary salt combinations and antiflatulents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AG | Antacids with antispasmodics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AH | Antacids with sodium bicarbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02AX | Antacids, other combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA | H2-receptor antagonists | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA01 | cimetidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA02 | ranitidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA03 | famotidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA04 | nizatidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA05 | niperotidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA06 | roxatidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA07 | ranitidine bismuth citrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA08 | lafutidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA51 | cimetidine, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BA53 | famotidine, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BB | Prostaglandins | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BB01 | misoprostol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BB02 | enprostil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC | Proton pump inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC01 | omeprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC02 | pantoprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC03 | lansoprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC04 | rabeprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC05 | esomeprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC06 | dexlansoprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC07 | dexrabeprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC08 | vonoprazan | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC09 | tegoprazan | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC10 | fexuprazan | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC11 | ilaprazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC51 | omeprazole, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC53 | lansoprazole, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BC54 | rabeprazole, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD | Combinations for eradication of Helicobacter pylori | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD01 | omeprazole, amoxicillin and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD02 | lansoprazole, tetracycline and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD03 | lansoprazole, amoxicillin and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD04 | pantoprazole, amoxicillin and clarithromycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD05 | omeprazole, amoxicillin and clarithromycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD06 | esomeprazole, amoxicillin and clarithromycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD07 | lansoprazole, amoxicillin and clarithromycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD08 | bismuth subcitrate, tetracycline and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD09 | lansoprazole, clarithromycin and tinidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD10 | lansoprazole, amoxicillin and levofloxacin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD11 | pantoprazole, amoxicillin, clarithromycin and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD12 | rabeprazole, amoxicillin and clarithromycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD13 | rabeprazole, amoxicillin and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD14 | vonoprazan, amoxicillin and clarithromycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD15 | vonoprazan, amoxicillin and metronidazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD16 | omeprazole, amoxicillin and rifabutin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BD17 | vonoprazan and amoxicillin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX01 | carbenoxolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX02 | sucralfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX03 | pirenzepine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX04 | methiosulfonium chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX05 | bismuth subcitrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX06 | proglumide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX07 | gefarnate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX08 | sulglicotide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX09 | acetoxolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX10 | zolimidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX11 | troxipide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX12 | bismuth subnitrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX13 | alginic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX14 | rebamipide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX15 | teprenone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX16 | irsogladine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX51 | carbenoxolone, combinations excl. psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX71 | carbenoxolone, combinations with psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02BX77 | gefarnate, combinations with psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A02X | OTHER DRUGS FOR ACID RELATED DISORDERS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03 | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03A | DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA | Synthetic anticholinergics, esters with tertiary amino group | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA01 | oxyphencyclimine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA03 | camylofin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA04 | mebeverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA05 | trimebutine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA06 | rociverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA07 | dicycloverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA08 | dihexyverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA09 | difemerine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AA30 | piperidolate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB | Synthetic anticholinergics, quaternary ammonium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB01 | benzilone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB02 | glycopyrronium bromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB03 | oxyphenonium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB04 | penthienate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB05 | propantheline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB06 | otilonium bromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB07 | methantheline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB08 | tridihexethyl | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB09 | isopropamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB10 | hexocyclium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB11 | poldine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB12 | mepenzolate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB13 | bevonium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB14 | pipenzolate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB15 | diphemanil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB16 | (2-benzhydryloxyethyl)diethyl-methylammonium iodide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB17 | tiemonium iodide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB18 | prifinium bromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB19 | timepidium bromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB21 | fenpiverinium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AB53 | oxyphenonium, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AC | Synthetic antispasmodics, amides with tertiary amines | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AC02 | dimethylaminopropionylphenothiazine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AC04 | nicofetamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AC05 | tiropramide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AD | Papaverine and derivatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AD01 | papaverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AD02 | drotaverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AD30 | moxaverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AE | Serotonin receptor antagonists | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AE01 | alosetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AE03 | cilansetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX | Other drugs for functional gastrointestinal disorders | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX01 | fenpiprane | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX02 | diisopromine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX03 | chlorbenzoxamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX04 | pinaverium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX05 | fenoverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX06 | idanpramine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX07 | proxazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX08 | alverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX09 | trepibutone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX10 | isometheptene | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX11 | caroverine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX12 | phloroglucinol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX13 | silicones | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX14 | valethamate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX15 | menthae piperitae aetheroleum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX30 | trimethyldiphenylpropylamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03AX58 | alverine, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03B | BELLADONNA AND DERIVATIVES, PLAIN | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BA | Belladonna alkaloids, tertiary amines | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BA01 | atropine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BA03 | hyoscyamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BA04 | belladonna total alkaloids | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB | Belladonna alkaloids, semisynthetic, quaternary ammonium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB01 | butylscopolamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB02 | methylatropine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB03 | methylscopolamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB04 | fentonium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB05 | cimetropium bromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03BB06 | homatropine methylbromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03C | ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA | Synthetic anticholinergic agents in combination with psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA01 | isopropamide and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA02 | clidinium and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA03 | oxyphencyclimine and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA04 | otilonium bromide and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA05 | glycopyrronium bromide and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA06 | bevonium and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA07 | ambutonium and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA08 | diphemanil and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA09 | pipenzolate and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA30 | emepronium and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CA34 | propantheline and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CB | Belladonna and derivatives in combination with psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CB01 | methylscopolamine and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CB02 | belladonna total alkaloids and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CB03 | atropine and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CB04 | homatropine methylbromide and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CB31 | hyoscyamine and psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03CC | Other antispasmodics in combination with psycholeptics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03D | ANTISPASMODICS IN COMBINATION WITH ANALGESICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA | Synthetic anticholinergic agents in combination with analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA01 | tropenzilone and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA02 | pitofenone and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA03 | bevonium and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA04 | ciclonium and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA05 | camylofin and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA06 | trospium and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DA07 | tiemonium iodide and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DB | Belladonna and derivatives in combination with analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DB04 | butylscopolamine and analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03DC | Other antispasmodics in combination with analgesics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03E | ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03EA | Antispasmodics, psycholeptics and analgesics in combination | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03ED | Antispasmodics in combination with other drugs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03F | PROPULSIVES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA | Propulsives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA01 | metoclopramide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA02 | cisapride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA03 | domperidone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA04 | bromopride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA05 | alizapride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA06 | clebopride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA07 | itopride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA08 | cinitapride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA09 | mosapride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A03FA10 | acotiamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04 | ANTIEMETICS AND ANTINAUSEANTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04A | ANTIEMETICS AND ANTINAUSEANTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA | Serotonin (5HT3) antagonists | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA01 | ondansetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA02 | granisetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA03 | tropisetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA04 | dolasetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA05 | palonosetron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AA55 | palonosetron, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD | Other antiemetics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD01 | scopolamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD02 | cerium oxalate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD04 | chlorobutanol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD05 | metopimazine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD10 | dronabinol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD11 | nabilone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD12 | aprepitant | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD13 | casopitant | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD14 | rolapitant | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD51 | scopolamine, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A04AD54 | chlorobutanol, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05 | BILE AND LIVER THERAPY | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05A | BILE THERAPY | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AA | Bile acids and derivatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AA01 | chenodeoxycholic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AA02 | ursodeoxycholic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AA03 | cholic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AA04 | obeticholic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AA05 | ursodoxicoltaurine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AB | Preparations for biliary tract therapy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AB01 | nicotinyl methylamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX | Other drugs for bile therapy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX01 | piprozolin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX02 | hymecromone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX03 | cyclobutyrol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX04 | maralixibat chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX05 | odevixibat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX06 | elafibranor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05AX07 | seladelpar | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05B | LIVER THERAPY, LIPOTROPICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA | Liver therapy | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA01 | arginine glutamate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA03 | silymarin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA04 | citiolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA05 | epomediol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA06 | ornithine oxoglurate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA07 | tidiacic arginine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA08 | glycyrrhizic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA09 | metadoxine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05BA10 | phospholipids | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A05C | DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06 | DRUGS FOR CONSTIPATION | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06A | DRUGS FOR CONSTIPATION | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AA | Softeners, emollients | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AA01 | liquid paraffin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AA02 | docusate sodium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AA51 | liquid paraffin, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB | Contact laxatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB01 | oxyphenisatine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB02 | bisacodyl | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB03 | dantron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB04 | phenolphthalein | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB05 | castor oil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB06 | senna glycosides | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB07 | cascara | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB08 | sodium picosulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB09 | bisoxatin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB20 | contact laxatives in combination | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB30 | contact laxatives in combination with belladonna alkaloids | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB52 | bisacodyl, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB53 | dantron, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB56 | senna glycosides, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB57 | cascara, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AB58 | sodium picosulfate, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC | Bulk-forming laxatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC01 | ispaghula (psylla seeds) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC02 | ethulose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC03 | sterculia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC05 | linseed | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC06 | methylcellulose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC07 | triticum (wheat fibre) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC08 | polycarbophil calcium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC51 | ispaghula, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC53 | sterculia, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AC55 | linseed, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD | Osmotically acting laxatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD01 | magnesium carbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD02 | magnesium oxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD03 | magnesium peroxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD04 | magnesium sulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD10 | mineral salts in combination | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD11 | lactulose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD12 | lactitol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD13 | sodium sulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD14 | pentaerithrityl | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD15 | macrogol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD16 | mannitol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD17 | sodium phosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD18 | sorbitol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD19 | magnesium citrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD21 | sodium tartrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD61 | lactulose, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AD65 | macrogol, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG | Enemas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG01 | sodium phosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG02 | bisacodyl | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG03 | dantron, incl. combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG04 | glycerol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG06 | oil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG07 | sorbitol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG10 | docusate sodium, incl. combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG11 | sodium lauryl sulfoacetate, incl. combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AG20 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AH | Peripheral opioid receptor antagonists | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AH01 | methylnaltrexone bromide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AH02 | alvimopan | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AH03 | naloxegol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AH04 | naloxone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AH05 | naldemedine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX | Other drugs for constipation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX01 | glycerol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX02 | carbon dioxide producing drugs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX03 | lubiprostone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX04 | linaclotide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX05 | prucalopride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX06 | tegaserod | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX07 | plecanatide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX08 | tenapanor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A06AX09 | elobixibat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07 | ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07A | INTESTINAL ANTIINFECTIVES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA | Antibiotics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA01 | neomycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA02 | nystatin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA03 | natamycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA04 | streptomycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA05 | polymyxin B | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA06 | paromomycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA07 | amphotericin B | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA08 | kanamycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA09 | vancomycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA10 | colistin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA11 | rifaximin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA12 | fidaxomicin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA13 | rifamycin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA51 | neomycin, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AA54 | streptomycin, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AB | Sulfonamides | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AB02 | phthalylsulfathiazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AB03 | sulfaguanidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AB04 | succinylsulfathiazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AC | Imidazole derivatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AC01 | miconazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AX | Other intestinal antiinfectives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AX01 | broxyquinoline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AX02 | acetarsol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AX03 | nifuroxazide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07AX04 | nifurzide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07B | INTESTINAL ADSORBENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BA | Charcoal preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BA01 | medicinal charcoal | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BA51 | medicinal charcoal, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BB | Bismuth preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC | Other intestinal adsorbents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC01 | pectin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC02 | kaolin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC03 | crospovidone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC04 | attapulgite | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC05 | diosmectite | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07BC54 | attapulgite, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07C | ELECTROLYTES WITH CARBOHYDRATES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07CA | Oral rehydration salt formulations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07D | ANTIPROPULSIVES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA | Antipropulsives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA01 | diphenoxylate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA02 | opium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA03 | loperamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA04 | difenoxin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA05 | loperamide oxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA06 | eluxadoline | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA52 | morphine, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07DA53 | loperamide, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07E | INTESTINAL ANTIINFLAMMATORY AGENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA | Corticosteroids acting locally | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA01 | prednisolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA02 | hydrocortisone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA03 | prednisone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA04 | betamethasone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA05 | tixocortol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA06 | budesonide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EA07 | beclometasone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EB | Antiallergic agents, excl. corticosteroids | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EB01 | cromoglicic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EC | Aminosalicylic acid and similar agents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EC01 | sulfasalazine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EC02 | mesalazine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EC03 | olsalazine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07EC04 | balsalazide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07F | ANTIDIARRHEAL MICROORGANISMS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07FA | Antidiarrheal microorganisms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07FA01 | lactic acid producing organisms | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07FA02 | saccharomyces boulardii | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07FA03 | escherichia coli | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07FA51 | lactic acid producing organisms, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07X | OTHER ANTIDIARRHEALS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA | Other antidiarrheals | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA01 | albumin tannate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA02 | ceratonia | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA03 | calcium compounds | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA04 | racecadotril | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA06 | crofelemer | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A07XA51 | albumin tannate, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08 | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08A | ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA | Centrally acting antiobesity products | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA01 | phentermine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA02 | fenfluramine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA03 | amfepramone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA04 | dexfenfluramine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA05 | mazindol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA06 | etilamfetamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA07 | cathine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA08 | clobenzorex | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA09 | mefenorex | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA10 | sibutramine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA11 | lorcaserin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA12 | setmelanotide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA51 | phentermine and topiramate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA56 | ephedrine, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AA62 | bupropion and naltrexone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AB | Peripherally acting antiobesity products | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AB01 | orlistat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AX | Other antiobesity drugs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A08AX01 | rimonabant | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09 | DIGESTIVES, INCL. ENZYMES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09A | DIGESTIVES, INCL. ENZYMES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AA | Enzyme preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AA01 | diastase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AA02 | multienzymes (lipase, protease etc.) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AA03 | pepsin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AA04 | tilactase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AB | Acid preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AB01 | glutamic acid hydrochloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AB02 | betaine hydrochloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AB03 | hydrochloric acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AB04 | citric acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AC | Enzyme and acid preparations, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AC01 | pepsin and acid preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A09AC02 | multienzymes and acid preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10 | DRUGS USED IN DIABETES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10A | INSULINS AND ANALOGUES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB | Insulins and analogues for injection, fast-acting | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB01 | insulin (human) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB02 | insulin (beef) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB03 | insulin (pork) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB04 | insulin lispro | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB05 | insulin aspart | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB06 | insulin glulisine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AB30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AC | Insulins and analogues for injection, intermediate-acting | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AC01 | insulin (human) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AC02 | insulin (beef) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AC03 | insulin (pork) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AC04 | insulin lispro | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AC30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD | Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD01 | insulin (human) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD02 | insulin (beef) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD03 | insulin (pork) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD04 | insulin lispro | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD05 | insulin aspart | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD06 | insulin degludec and insulin aspart | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AD30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE | Insulins and analogues for injection, long-acting | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE01 | insulin (human) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE02 | insulin (beef) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE03 | insulin (pork) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE04 | insulin glargine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE05 | insulin detemir | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE06 | insulin degludec | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE07 | insulin icodec | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE54 | insulin glargine and lixisenatide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AE56 | insulin degludec and liraglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AF | Insulins and analogues for inhalation | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10AF01 | insulin (human) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10B | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BA | Biguanides | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BA01 | phenformin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BA02 | metformin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BA03 | buformin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB | Sulfonylureas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB01 | glibenclamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB02 | chlorpropamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB03 | tolbutamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB04 | glibornuride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB05 | tolazamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB06 | carbutamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB07 | glipizide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB08 | gliquidone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB09 | gliclazide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB10 | metahexamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB11 | glisoxepide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB12 | glimepiride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BB31 | acetohexamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BC | Sulfonamides (heterocyclic) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BC01 | glymidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD | Combinations of oral blood glucose lowering drugs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD01 | phenformin and sulfonylureas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD02 | metformin and sulfonylureas | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD03 | metformin and rosiglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD04 | glimepiride and rosiglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD05 | metformin and pioglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD06 | glimepiride and pioglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD07 | metformin and sitagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD08 | metformin and vildagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD09 | pioglitazone and alogliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD10 | metformin and saxagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD11 | metformin and linagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD12 | pioglitazone and sitagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD13 | metformin and alogliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD14 | metformin and repaglinide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD15 | metformin and dapagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD16 | metformin and canagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD17 | metformin and acarbose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD18 | metformin and gemigliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD19 | linagliptin and empagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD20 | metformin and empagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD21 | saxagliptin and dapagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD22 | metformin and evogliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD23 | metformin and ertugliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD24 | sitagliptin and ertugliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD25 | metformin, saxagliptin and dapagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD26 | metformin and lobeglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD27 | metformin, linagliptin and empagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD28 | metformin and teneligliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD29 | sitagliptin and dapagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BD30 | gemigliptin and dapagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BF | Alpha glucosidase inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BF01 | acarbose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BF02 | miglitol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BF03 | voglibose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BG | Thiazolidinediones | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BG01 | troglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BG02 | rosiglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BG03 | pioglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BG04 | lobeglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH | Dipeptidyl peptidase 4 (DPP-4) inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH01 | sitagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH02 | vildagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH03 | saxagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH04 | alogliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH05 | linagliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH06 | gemigliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH07 | evogliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH08 | teneligliptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH51 | sitagliptin and simvastatin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BH52 | gemigliptin and rosuvastatin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ | Glucagon-like peptide-1 (GLP-1) analogues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ01 | exenatide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ02 | liraglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ03 | lixisenatide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ04 | albiglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ05 | dulaglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ06 | semaglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BJ07 | beinaglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK | Sodium-glucose co-transporter 2 (SGLT2) inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK01 | dapagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK02 | canagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK03 | empagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK04 | ertugliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK05 | ipragliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK06 | sotagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK07 | luseogliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK08 | bexagliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BK09 | enavogliflozin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX | Other blood glucose lowering drugs, excl. insulins | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX01 | guar gum | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX02 | repaglinide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX03 | nateglinide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX05 | pramlintide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX06 | benfluorex | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX08 | mitiglinide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX15 | imeglimin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX16 | tirzepatide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX17 | carfloglitazar | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10BX18 | dorzagliatin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10X | OTHER DRUGS USED IN DIABETES | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10XA | Aldose reductase inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10XA01 | tolrestat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10XX | Other drugs used in diabetes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10XX01 | teplizumab | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A10XX02 | donislecel | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11 | VITAMINS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11A | MULTIVITAMINS, COMBINATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11AA | Multivitamins with minerals | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11AA01 | multivitamins and iron | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11AA02 | multivitamins and calcium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11AA03 | multivitamins and other minerals, incl. combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11AA04 | multivitamins and trace elements | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11AB | Multivitamins, other combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11B | MULTIVITAMINS, PLAIN | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11BA | Multivitamins, plain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11C | VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CA | Vitamin A, plain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CA01 | retinol (vit A) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CA02 | betacarotene | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CB | Vitamin A and D in combination | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC | Vitamin D and analogues | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC01 | ergocalciferol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC02 | dihydrotachysterol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC03 | alfacalcidol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC04 | calcitriol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC05 | colecalciferol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC06 | calcifediol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC20 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11CC55 | colecalciferol, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11D | VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11DA | Vitamin B1, plain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11DA01 | thiamine (vit B1) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11DA02 | sulbutiamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11DA03 | benfotiamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11DB | Vitamin B1 in combination with vitamin B6 and/or vitamin B12 | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11E | VITAMIN B-COMPLEX, INCL. COMBINATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11EA | Vitamin B-complex, plain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11EB | Vitamin B-complex with vitamin C | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11EC | Vitamin B-complex with minerals | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11ED | Vitamin B-complex with anabolic steroids | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11EX | Vitamin B-complex, other combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11G | ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11GA | Ascorbic acid (vitamin C), plain | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11GA01 | ascorbic acid (vit C) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11GB | Ascorbic acid (vitamin C), combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11GB01 | ascorbic acid (vit C) and calcium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11H | OTHER PLAIN VITAMIN PREPARATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA | Other plain vitamin preparations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA01 | nicotinamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA02 | pyridoxine (vit B6) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA03 | tocopherol (vit E) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA04 | riboflavin (vit B2) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA05 | biotin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA06 | pyridoxal phosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA07 | inositol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA08 | tocofersolan | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA30 | dexpanthenol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA31 | calcium pantothenate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11HA32 | pantethine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11J | OTHER VITAMIN PRODUCTS, COMBINATIONS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11JA | Combinations of vitamins | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11JB | Vitamins with minerals | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A11JC | Vitamins, other combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12 | MINERAL SUPPLEMENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12A | CALCIUM | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA | Calcium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA01 | calcium phosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA02 | calcium glubionate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA03 | calcium gluconate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA04 | calcium carbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA05 | calcium lactate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA06 | calcium lactate gluconate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA07 | calcium chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA08 | calcium glycerylphosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA09 | calcium citrate lysine complex | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA10 | calcium glucoheptonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA11 | calcium pangamate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA13 | calcium citrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA20 | calcium (different salts in combination) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AA30 | calcium laevulate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12AX | Calcium, combinations with vitamin D and/or other drugs | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12B | POTASSIUM | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA | Potassium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA01 | potassium chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA02 | potassium citrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA03 | potassium hydrogentartrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA04 | potassium hydrogencarbonate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA05 | potassium gluconate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA30 | potassium (different salts in combination) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12BA51 | potassium, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12C | OTHER MINERAL SUPPLEMENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CA | Sodium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CA01 | sodium chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CA02 | sodium sulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CB | Zinc | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CB01 | zinc sulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CB02 | zinc gluconate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CB03 | zinc protein complex | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC | Magnesium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC01 | magnesium chloride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC02 | magnesium sulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC03 | magnesium gluconate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC04 | magnesium citrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC05 | magnesium aspartate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC06 | magnesium lactate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC07 | magnesium levulinate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC08 | magnesium pidolate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC09 | magnesium orotate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC10 | magnesium oxide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CC30 | magnesium (different salts in combination) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CD | Fluoride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CD01 | sodium fluoride | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CD02 | sodium monofluorophosphate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CD51 | fluoride, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CE | Selenium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CE01 | sodium selenate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CE02 | sodium selenite | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A12CX | Other mineral products | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A13 | TONICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A13A | TONICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14 | ANABOLIC AGENTS FOR SYSTEMIC USE | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14A | ANABOLIC STEROIDS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA | Androstan derivatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA01 | androstanolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA02 | stanozolol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA03 | metandienone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA04 | metenolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA05 | oxymetholone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA06 | quinbolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA07 | prasterone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA08 | oxandrolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AA09 | norethandrolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AB | Estren derivatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AB01 | nandrolone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AB02 | ethylestrenol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14AB03 | oxabolone cipionate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A14B | OTHER ANABOLIC AGENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A15 | APPETITE STIMULANTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16 | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16A | OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA | Amino acids and derivatives | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA01 | levocarnitine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA02 | ademetionine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA03 | glutamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA04 | mercaptamine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA05 | carglumic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA06 | betaine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AA07 | metreleptin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB | Enzymes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB01 | alglucerase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB02 | imiglucerase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB03 | agalsidase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB04 | agalsidase beta | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB05 | laronidase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB06 | sacrosidase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB07 | alglucosidase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB08 | galsulfase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB09 | idursulfase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB10 | velaglucerase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB11 | taliglucerase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB12 | elosulfase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB13 | asfotase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB14 | sebelipase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB15 | velmanase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB16 | idursulfase beta | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB17 | cerliponase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB18 | vestronidase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB19 | pegvaliase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB20 | pegunigalsidase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB21 | atidarsagene autotemcel | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB22 | avalglucosidase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB23 | cipaglucosidase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB24 | pegzilarginase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB25 | olipudase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB26 | eladocagene exuparvovec | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AB27 | pabinafusp alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX | Various alimentary tract and metabolism products | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX01 | thioctic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX02 | anethole trithione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX03 | sodium phenylbutyrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX04 | nitisinone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX05 | zinc acetate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX06 | miglustat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX07 | sapropterin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX08 | teduglutide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX09 | glycerol phenylbutyrate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX10 | eliglustat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX11 | sodium benzoate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX12 | trientine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX13 | uridine triacetate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX14 | migalastat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX15 | telotristat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX16 | givosiran | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX17 | triheptanoin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX18 | lumasiran | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX19 | fosdenopterin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX20 | lonafarnib | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX21 | elivaldogene autotemcel | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX22 | tiomolibdic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX23 | leriglitazone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX24 | govorestat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX25 | nedosiran | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | A16AX30 | sodium benzoate and sodium phenylacetate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B | BLOOD AND BLOOD FORMING ORGANS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01 | ANTITHROMBOTIC AGENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01A | ANTITHROMBOTIC AGENTS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA | Vitamin K antagonists | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA01 | dicoumarol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA02 | phenindione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA03 | warfarin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA04 | phenprocoumon | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA07 | acenocoumarol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA08 | ethyl biscoumacetate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA09 | clorindione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA10 | diphenadione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA11 | tioclomarol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AA12 | fluindione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB | Heparin group | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB01 | heparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB02 | antithrombin III | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB04 | dalteparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB05 | enoxaparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB06 | nadroparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB07 | parnaparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB08 | reviparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB09 | danaparoid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB10 | tinzaparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB11 | sulodexide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB12 | bemiparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AB51 | heparin, combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC | Platelet aggregation inhibitors excl. heparin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC01 | ditazole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC02 | cloricromen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC03 | picotamide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC04 | clopidogrel | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC05 | ticlopidine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC06 | acetylsalicylic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC07 | dipyridamole | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC08 | carbasalate calcium | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC09 | epoprostenol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC10 | indobufen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC11 | iloprost | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC13 | abciximab | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC15 | aloxiprin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC16 | eptifibatide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC17 | tirofiban | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC18 | triflusal | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC19 | beraprost | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC21 | treprostinil | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC22 | prasugrel | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC23 | cilostazol | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC24 | ticagrelor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC25 | cangrelor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC26 | vorapaxar | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC27 | selexipag | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC28 | limaprost | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AC56 | acetylsalicylic acid, combinations with proton pump inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD | Enzymes | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD01 | streptokinase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD02 | alteplase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD03 | anistreplase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD04 | urokinase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD05 | fibrinolysin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD06 | brinase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD07 | reteplase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD08 | saruplase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD09 | ancrod | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD10 | drotrecogin alfa (activated) | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD11 | tenecteplase | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD12 | protein C | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AD13 | apadamtase alfa and cinaxadamtase alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE | Direct thrombin inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE01 | desirudin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE02 | lepirudin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE03 | argatroban | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE04 | melagatran | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE05 | ximelagatran | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE06 | bivalirudin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AE07 | dabigatran etexilate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AF | Direct factor Xa inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AF01 | rivaroxaban | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AF02 | apixaban | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AF03 | edoxaban | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AF04 | betrixaban | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AF51 | rivaroxaban and acetylsalicylic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AX | Other antithrombotic agents | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AX01 | defibrotide | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AX04 | dermatan sulfate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AX05 | fondaparinux | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B01AX07 | caplacizumab | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02 | ANTIHEMORRHAGICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02A | ANTIFIBRINOLYTICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AA | Amino acids | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AA01 | aminocaproic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AA02 | tranexamic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AA03 | aminomethylbenzoic acid | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AB | Proteinase inhibitors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AB01 | aprotinin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AB02 | alfa1 antitrypsin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AB04 | camostat | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02AB05 | ulinastatin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02B | VITAMIN K AND OTHER HEMOSTATICS | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BA | Vitamin K | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BA01 | phytomenadione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BA02 | menadione | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BB | Fibrinogen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BB01 | fibrinogen, human | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC | Local hemostatics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC01 | absorbable gelatin sponge | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC02 | oxidized cellulose | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC03 | tetragalacturonic acid hydroxymethylester | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC05 | adrenalone | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC06 | thrombin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC07 | collagen | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC08 | calcium alginate | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC09 | epinephrine | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BC30 | combinations | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD | Blood coagulation factors | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD01 | coagulation factor IX, II, VII and X in combination | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD02 | coagulation factor VIII | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD03 | factor VIII inhibitor bypassing activity | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD04 | coagulation factor IX | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD05 | coagulation factor VII | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD06 | von Willebrand factor and coagulation factor VIII in combination | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD07 | coagulation factor XIII | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD08 | coagulation factor VIIa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD10 | von Willebrand factor | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD11 | catridecacog | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD13 | coagulation factor X | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD14 | susoctocog alfa | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD15 | valoctocogene roxaparvovec | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD16 | etranacogene dezaparvovec | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD17 | fidanacogene elaparvovec | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BD30 | thrombin | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BX | Other systemic hemostatics | ||
https://nshr-uat.sha.go.ke/fhir/CodeSystem/kps-medication-atc-cs | B02BX01 | etamsylate |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |